Vaccinations in prisons: A shot in the arm for community health

References

• Engginst S, Møller L, Galea G, Udensen C. Prisons and Health. Copenhagen: WHO, Regional Office for Europe; 2014
   Google Scholar
• Bick JA. Infection control in jails and prisons. Clin Infect Dis 2007;45(8):1047-55; PMID:17879924; http://dx.doi.org/10.1086/521910
   PubMed Web of Science ®Google Scholar
• Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines. In Plotkin S, Orenstein W, Offit PA. 5th ed. Philadelphia, PA: WB Saunders; 2008
   Google Scholar
• Sequera VG, Garcia-Basteiro A, Bayas J. The role of vaccination in prisoners' health. Expert Rev Vaccines 2013; 12(5):469-71; PMID:23659294; http://dx.doi.org/10.1586/erv.13.28
   PubMed Web of Science ®Google Scholar
• Sequera VG, Bayas JM. Vaccination in the prison population: a review. Rev Esp Sanid Penit 2012; (14):99-105; PMID:23165633; http://dx.doi.org/10.4321/S1575-06202012000300005
   PubMedGoogle Scholar
• Moller L, Stöver H, Jürgens R, Gatherer A, Nikogosian H. Health in Prisons. A WHO guide to the essential in prison health. Copenhagen: WHO, Regional Office for Europe; 2007
   Google Scholar
• Hatton DC, Kleffel D, Fisher AA. Prisoners' perspectives of health problems and healthcare in a US women's jail. Women Health 2006; 44(1):119-36; PMID:17182530; http://dx.doi.org/10.1300/J013v44n01_07
   PubMed Web of Science ®Google Scholar
• McGuire J, Rosenheck RA, Kasprow WJ. Health status, service use, and costs among veterans receiving outreach services in jail or community settings. Psychiatr Serv 2003; 54(2):201-7; PMID:12556601; http://dx.doi.org/10.1176/appi.ps.54.2.201
   PubMed Web of Science ®Google Scholar
• National Institute of Statistics. Prison population by nationality, sex and period, Spain 2014. http://www.ine.es/jaxi/tabla.do. Accesed February 15, 2015
   Google Scholar
• Hockings B, Young M, Falconer A, O'Rourke PK. Queensland women prisoners' health survey. Department of Corrective Service: Brisbane; 2002. https://nationalvetcontent.edu.au/alfresco/d/d/workspace/SpacesStore/c6f6a435-62d2-4c90-b052-42904ac2f5e3/701/shared/content/resources/health_women2.pdf. Accessed January 11, 2015
   Google Scholar
• Bickell N, Vermund S. Human papillomavirus, gonorrhea, syphilis, and cervical dysplasia in jailed women. Am J Public Heal 1991; 81(10):1318-20; PMID:1928533; http://dx.doi.org/10.2105/AJPH.81.10.1318
   PubMed Web of Science ®Google Scholar
• Williams B, Goodwin J. Addressing the aging crisis in US criminal justice health care. J Am Geriatr Soc 2012; 60(6):1150-6; PMID:22642489; http://dx.doi.org/10.1111/j.1532-5415.2012.03962.x
   PubMed Web of Science ®Google Scholar
• Besdine R, Boult C, Brangman S, Coleman EA, Fried LP, Gerety M, Johnson JC, Katz PR, Potter JF, Reuben DB, et al. Caring for older Americans: the future of geriatric medicine. J Am Geriatr Soc 2005; 53(6 Suppl):S245-56; PMID:15963180
   PubMed Web of Science ®Google Scholar
• Williams BA, McGuire J, Lindsay RG, Baillargeon J, Cenzer IS, Lee SJ, Kushel M. Coming home: health status and homelessness risk of older pre-release prisoners. J Gen Intern Med 2010; 25(10):1038-44; PMID:20532651; http://dx.doi.org/10.1007/s11606-010-1416-8
   PubMed Web of Science ®Google Scholar
• Baillargeon J, Black SA, Leach CT, Jenson H, Pulvino J, Bradshaw P, Murray O. The infectious disease profile of Texas prison inmates. Prev Med 2004; 38(5):607-12; PMID:15066363; http://dx.doi.org/10.1016/j.ypmed.2003.11.020
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Prisons and Drugs in Europe: the problem and responses. Luxembourg: Publication Office of the European Union; 2012. http://www.emcdda.europa.eu/publications/selected-issues/prison. Accessed January 11, 2015
   Google Scholar
• Ritter C, Stover H, Levy M, Etter JF, Elger B. Smoking in prisons: the need for effective and acceptable interventions. J Public Health Policy 2011; 32(1):32-45; PMID:21160535; http://dx.doi.org/10.1057/jphp.2010.47
   PubMed Web of Science ®Google Scholar
• Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006; 101(2):181-91; PMID:16445547; http://dx.doi.org/10.1111/j.1360-0443.2006.01316.x
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Krueger PM, Steiner JF. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health 2009 Nov; 63(11):912-9; PMID:19648129; http://dx.doi.org/10.1136/jech.2009.090662
   PubMed Web of Science ®Google Scholar
• Fazel S, Baillargeon J. The health of prisoners. Lancet 2011; 377(9769):956-65; PMID:21093904; http://dx.doi.org/10.1016/S0140-6736(10)61053-7
   PubMed Web of Science ®Google Scholar
• Thorburn K. Health care in correctional facilities. West J Med 1995; 163(6):560-4; PMID:8553640
   PubMedGoogle Scholar
• Mathew P, Elting L, Cooksley C, Owen S, Lin J. Cancer in an incarcerated population. Cancer 2005; 104(10):2197-204; PMID:16206295; http://dx.doi.org/10.1002/cncr.21468
   PubMed Web of Science ®Google Scholar
• Garcia-Guerrero J, Vera-Remartinez EJ, Planelles Ramos MV. [Causes and trends of mortality in a Spanish prison (1994-2009)]. Rev Esp Salud Publica 2011 Jun; 85(3):245-55; PMID:21892549; http://dx.doi.org/10.1590/S1135-57272011000300003
   PubMed Web of Science ®Google Scholar
• Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med 2010; 7(12):e1000381; PMID:21203587; http://dx.doi.org/10.1371/journal.pmed.1000381
   PubMed Web of Science ®Google Scholar
• World Hearlh Organization. Global Tuberculosis Report 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf. Accessde January 11, 2015
   Google Scholar
• Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92(11):1789-94; PMID:12406810; http://dx.doi.org/10.2105/AJPH.92.11.1789
   PubMed Web of Science ®Google Scholar
• Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002; 35(3):305-12; PMID:12115097; http://dx.doi.org/10.1086/341418
   PubMed Web of Science ®Google Scholar
• Kirwan P, Evans B, Brant L. Hepatitis C and B testing in English prisons is low but increasing. J Public Health 2011; 33(2):197-204; PMID:21345883; http://dx.doi.org/10.1093/pubmed/fdr011
   PubMed Web of Science ®Google Scholar
• Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Quaye IKE, Hesse IF, Mensah G. Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre study. J Med Microbiol 2007; 56(Pt 3):391-7; PMID:17314372; http://dx.doi.org/10.1099/jmm.0.46859-0
   PubMed Web of Science ®Google Scholar
• Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. J Infect Public Health 2013; 6(3):186-95; PMID:23668463; http://dx.doi.org/10.1016/j.jiph.2012.12.003
   PubMedGoogle Scholar
• Saiz de la Hoya P, Marco A, García-Guerrero J, Rivera A. Hepatitis C and B prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis 2011; 30(7):857-62; PMID:21274586; http://dx.doi.org/10.1007/s10096-011-1166-5
   PubMed Web of Science ®Google Scholar
• Gough E, Kempf MC, Graham L, Manzanero M, Hook EW, Bartolucci A, Chamot E. HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. BMC Public Health 2010; 10:777; PMID:21176146; http://dx.doi.org/10.1186/1471-2458-10-777
   PubMed Web of Science ®Google Scholar
• Pomplillo MA, Pontes E, Castro A, Andrade SM, Stief AC, Martins RM, Mousquer GJ, Murat PG, Francisco RB, Pompilio S, et al. Prevalence and epidemiology of chronic hepatitis C among prisoners of Mato Grosso do Sul State, Brazil. J Venom Anim Toxins Incl Trop Dis 2011; 17(2):216-22; http://dx.doi.org/10.1590/S1678-91992011000200013
   Web of Science ®Google Scholar
• Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis 2010; 14(Suppl 3):e60-6; PMID:20189863; http://dx.doi.org/10.1016/j.ijid.2009.11.012
   PubMedGoogle Scholar
• Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, Kumar S, Butler TG. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010. Med J Aust 2014; 200(5):277-80; PMID:24641153; http://dx.doi.org/10.5694/mja13.11062
   PubMed Web of Science ®Google Scholar
• Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland W, Banifazi M, Mostafavi E, Eslamifar A, Sofian M. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran. AIDS Care 2014; 26(9):1122-6; PMID:24499303; http://dx.doi.org/10.1080/09540121.2014.882485
   PubMed Web of Science ®Google Scholar
• Larney S, Monkley DL, Indig D, Hampton SE. A cross-sectional study of susceptibility to vaccine-preventable diseases among prison entrants in New South Wales. Med J Aust 2013; 198(7):376-9; PMID:23581958; http://dx.doi.org/10.5694/mja12.11110
   PubMed Web of Science ®Google Scholar
• Kolaric B, Stajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. Cent Eur J Public Health 2010; 18(2):104-9; PMID:20939261
   PubMedGoogle Scholar
• Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000; 321(7253):78-82; PMID:10884256; http://dx.doi.org/10.1136/bmj.321.7253.78
   PubMed Web of Science ®Google Scholar
• Stief AC, Martins RM, Andrade SM, Pompilio MA, Fernandes SM, Murat PG, Mousquer GJ, Teles AS, Camolez GR, Francisco RB, et al. Seroprevalence of hepatitis B virus infection and associated factors among prison inmates in State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop 2010; 43(5):512-5; PMID:21085860; http://dx.doi.org/10.1590/S0037-86822010000500008
   PubMed Web of Science ®Google Scholar
• Tresó B, Barcsay E, Tarján A, Horváth G, Dencs A, Hettmann A, Csépai MM, Gyori Z, Rusvai E, Takács M. Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. J Urban Health 2012; 89(1):108-16; PMID:22143408; http://dx.doi.org/10.1007/s11524-011-9626-x
   PubMed Web of Science ®Google Scholar
• Harzke AJ, Goodman KJ, Mullen PD, Baillargeon J. Heterogeneity in hepatitis B virus (HBV) seroprevalence estimates from U.S. adult incarcerated opulations. Ann Epidemiol 2009; 19(9):647-50; PMID:19596205; http://dx.doi.org/10.1016/j.annepidem.2009.04.001
   PubMed Web of Science ®Google Scholar
• Saum C, Surratt H, Inciardi J, Bennett R. Sex in prison: exploring the myths and realities. Prison J 1995; 75(4):413-30; http://dx.doi.org/10.1177/0032855595075004002
   Google Scholar
• Hunt DR, Saab S. Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol 2009; 104(4):1024-31; PMID:19240708; http://dx.doi.org/10.1038/ajg.2008.143
   PubMed Web of Science ®Google Scholar
• Harawa N, Sweat J. Sex and condom use in a large jail unit for men who have sex with men (MSM) and male-to-female transgenders. J Health Care Poor Underserved 2010; 21(3): 1071-87; PMID:20693745; http://dx.doi.org/10.1353/hpu.0.0349
   PubMed Web of Science ®Google Scholar
• Wolff N, Shi J. Contextualization of physical and sexual assault in male prisons: Incidents and their aftermath. J Correct Heal Care 2009; 15(1):58-82; PMID:19477812; http://dx.doi.org/10.1177/1078345808326622
   PubMedGoogle Scholar
• Struckman-Johnson C, Struckman-Johnson D. Sexual coercion reported by women in three midwestern prisons. J Sex Res 2002; 39(3):217-27; PMID:12476269; http://dx.doi.org/10.1080/00224490209552144
   PubMed Web of Science ®Google Scholar
• Schneider K, Richters J, Butler T, Yap L, Richards A, Grant L, Smith AM, Donovan B. Psychological distress and experience of sexual and physical assault among Australian prisoners. Crim Behav Ment Health 2011 Dec; 21(5):333-49; PMID:21671444
   PubMed Web of Science ®Google Scholar
• Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons–not such a pretty picture. Am J Infect Control 2007; 35(7):477-80; PMID:17765561; http://dx.doi.org/10.1016/j.ajic.2006.08.002
   PubMed Web of Science ®Google Scholar
• Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 2004; 132(3):409-15; PMID:15188710; http://dx.doi.org/10.1017/S0950268803001882
   PubMed Web of Science ®Google Scholar
• Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health 2008; 62(4):305-13; PMID:18339822; http://dx.doi.org/10.1136/jech.2006.051599
   PubMed Web of Science ®Google Scholar
• Vong S, Fiore AE, Haight DO, Li J, Borgsmiller N, Kuhnert W, Pinero F, Boaz K, Badsgard T, Mancini C, et al. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis A outbreak among methamphetamine drug users. Vaccine 2005; 23(8):1021-8; PMID:15620475; http://dx.doi.org/10.1016/j.vaccine.2004.07.038
   PubMed Web of Science ®Google Scholar
• Zamani S, Farnia M, Torknejad A, Alaei BA, Gholizadeh M, Kasraee F, Ono-Kihara M, Oba K, Kihara M. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health 2010; 87(4):603-16; PMID:20390391; http://dx.doi.org/10.1007/s11524-010-9450-8
   PubMed Web of Science ®Google Scholar
• Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis United States; 2005 Jul; 41(2):177-86; PMID:15983913; http://dx.doi.org/10.1086/430913
   PubMed Web of Science ®Google Scholar
• Garcia-Guerrero J, Marco A. [Overcrowding in prisons and its impact on health]. Rev Esp Sanid Penit Spain 2012 Feb; 14(3):106-13; PMID:23165634; http://dx.doi.org/10.4321/S1575-06202012000300006
   PubMedGoogle Scholar
• Goldenson J, Hennessey M. Correctional health care must be recognized as an integral part of the public health sector. Sex Transm Dis 2009; 36(2 Suppl): S3-4; PMID:19131905; http://dx.doi.org/10.1097/OLQ.0b013e318195ad6c
   PubMedGoogle Scholar
• Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One 2009; 4(11):e7558; PMID:19907649; http://dx.doi.org/10.1371/journal.pone.0007558
   PubMed Web of Science ®Google Scholar
• Farrell M, Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008; 103(2):251-5; PMID:18199304; http://dx.doi.org/10.1111/j.1360-0443.2007.02081.x
   PubMed Web of Science ®Google Scholar
• Bayas JM, Bruguera M, Martin V, Vidal J, Rodes J, Salleras LY. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine 1993; 11(14):1441-4; PMID:8310764; http://dx.doi.org/10.1016/0264-410X(93)90174-V
   PubMed Web of Science ®Google Scholar
• Catalan-Soares B, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at. Rev Soc Bras Med Trop 2000; 33(1):27-30; PMID:10881115; http://dx.doi.org/10.1590/S0037-86822000000100004
   PubMedGoogle Scholar
• Mamo H. Intestinal parasitic infections among prison inmates and tobacco farm workers in Shewa Robit, north-central Ethiopia. PLoS One 2014; 9(6):e99559; PMID:24926687; http://dx.doi.org/10.1371/journal.pone.0099559
   PubMedGoogle Scholar
• World Health Organization. Hepatitis B. Fact Sheet N° 204, 2014. http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed January 11, 2015
   Google Scholar
• World Hepatitis Alliance. Global Community Hepatitis Policy Report 2014. http://www.worldhepatitisalliance.org/en/civil-society-report-2014.html. Accessed January 11, 2015
   Google Scholar
• Dana D, Zary N, Peyman A, Behrooz A. Risk prison and hepatitis B virus infection among inmates with history of drug injection in Isfahan, Iran. Sci World J 2013; 2013: 735761; PMID:23737725; http://dx.doi.org/10.1155/2013/735761
   PubMed Web of Science ®Google Scholar
• Burek V, Horvat J, Butorac K, Mikulić R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect 2010; 138(11):1610-20; PMID:20202285; http://dx.doi.org/10.1017/S0950268810000476
   PubMed Web of Science ®Google Scholar
• Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000; 3(2):121-6; PMID:10902255
   PubMedGoogle Scholar
• Campollo O, Roman S, Panduro A, Hernandez G, Diaz-Barriga L, Balanzario MC, Cunningham JK. Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 2012; 123(1–3):269-72; PMID:22138538; http://dx.doi.org/10.1016/j.drugalcdep.2011.11.009
   PubMed Web of Science ®Google Scholar
• Barros LA, Pessoni GC, Teles SA, Souza SM, Matos MA, Martins RM, Del-Rios NH, Matos MA, Carneiro MA. Major article epidemiology of the viral hepatitis B and C in female prisoners of metropolitan regional prison complex in the State of Goiás, Central Brazil. Rev Soc Bras Med Tro 2013; 46:24-9; http://dx.doi.org/10.1590/0037-868216972013
   PubMed Web of Science ®Google Scholar
• Coelho HC, Lourdes MD, Oliveira A, Dinis A, Passos C. Seroprevalence of Hepatitis B virus infection in a brazilian jail. Rev Bras Epidemiol 2009; 12(2):124-31; http://dx.doi.org/10.1590/S1415-790X2009000200003
   Google Scholar
• Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamfi C, Asare I, Hesse IF, Mensah G. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infect Dis 2008; 8:33; PMID:18328097; http://dx.doi.org/10.1186/1471-2334-8-33
   PubMed Web of Science ®Google Scholar
• Adoga MP, Banwat EB, Forbi JC, Nimzing L, Christopher R, Gyar SD, Agabi YA, Agwale SM. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries 2008; 3(7):539-47; PMID:19762972
   PubMedGoogle Scholar
• Carrieri MP, Rey D, Michel L. Universal hepatitis B virus vaccination in French prisons: breaking down the last barriers. Addiction 2010; 105(7): 1311-2; PMID:20642514; http://dx.doi.org/10.1111/j.1360-0443.2010.02968.x
   PubMed Web of Science ®Google Scholar
• Charuvastra A, Stein J, Schwartzapfel B, Spaulding A, Horowitz E, Macalino G, Rich JD. Hepatitis B vaccination practices in state and federal prisons. Public Health Rep 2001; 116(3):203-9; PMID:12034909; http://dx.doi.org/10.1093/phr/116.3.203
   PubMed Web of Science ®Google Scholar
• Pisu M, Meltzer MI, Lyerla R. Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine 2002; 21(3–4):312-21; PMID:12450707; http://dx.doi.org/10.1016/S0264-410X(02)00457-7
   PubMed Web of Science ®Google Scholar
• Dappah E, Howes S, Perkins S. Prevention of communicable disease control in prisons and places of detention. A manual for healthcare workers and other staff. Health Protection Agency and Department of Health 2013. https://www.gov.uk/government/publications/infection-control-in-prisons-and-places-of-detention. Accessed January 11, 2015
   Google Scholar
• Asli AAZ, Moghadami M, Zamiri N, Tolide-ei HR, Heydari ST, Alavian SM, Lankarani KB. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health Policy 2011; 100(2–3):297-304; PMID:21269722; http://dx.doi.org/10.1016/j.healthpol.2010.12.007
   PubMed Web of Science ®Google Scholar
• Alavian SM. Accelerated vaccination against HBV infection is an important strategy for the control of HBV infection in prisons. Rev Soc Bras Med Trop 2011; 44(5):652-3; PMID:22031090; http://dx.doi.org/10.1590/S0037-86822011000500030
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO position paper on hepatitis A vaccines – June 2012. Wkly Epidemiol Rec 2012 Jul 13; 87(28/29):261-76; PMID:22905367
   PubMedGoogle Scholar
• Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010 Sep 24;28(41):6653-7; PMID:20723630; http://dx.doi.org/10.1016/j.vaccine.2010.08.037
   PubMed Web of Science ®Google Scholar
• Ngui S, Granerod J, Jewes LA, Crowcroft NS, Teo C. Outbreaks of hepatitis A in England and Wales associated with two co-circulating hepatitis A virus strains. J Med Virol 2008; 80(7):1181-8; PMID:18461630; http://dx.doi.org/10.1002/jmv.21207
   PubMed Web of Science ®Google Scholar
• Rapicetta M, Monarca R, Kondili LA, Chionne P, Madonna E, Madeddu G, Soddu A, Candido A, Carbonara S, Mura MS, et al. Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. Infection 2013; 41(1):69-76; PMID:23264095; http://dx.doi.org/10.1007/s15010-012-0385-8
   PubMed Web of Science ®Google Scholar
• Perrett K, Granerod J, Crowcroft N, Carlisle R. Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users? Commun Dis Public Health 2003; 6(2):97-100; PMID:12889286
   PubMedGoogle Scholar
• Franco E, Giambi C, Ialacci R, Coppola RC, Zanetti AR. Risk groups for hepatitis A virus infection. Vaccine 2003; 21(19–20):2224-33; PMID:12744847; http://dx.doi.org/10.1016/S0264-410X(03)00137-3
   PubMed Web of Science ®Google Scholar
• Latimer WW, Moleko A-G, Melnikov A, Mitchell M, Severtson SG, von Thomsen S, Graham C, Alama D, Floyd L. Prevalence and correlates of hepatitis A among adult drug users: the significance of incarceration and race/ethnicity. Vaccine 2007; 25(41):7125-31; PMID:17766016; http://dx.doi.org/10.1016/j.vaccine.2007.07.041
   PubMed Web of Science ®Google Scholar
• Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. BMC Public Health 2011; 11:351; PMID:21595969; http://dx.doi.org/10.1186/1471-2458-11-351
   PubMed Web of Science ®Google Scholar
• Gondles EF. A call to immunize the correctional population for hepatitis A and B. Am J Med 2005; 118(Suppl 10A):84S-89S; PMID:16271547; http://dx.doi.org/10.1016/j.amjmed.2005.07.025
   PubMedGoogle Scholar
• Weinbaum C, Lyerla R, Margolis HS, Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep 2003; 52(RR-1):1-36; PMID:12562146
   PubMedGoogle Scholar
• Coffey E, Young D. Guidance for hepatitis A and B vaccination of drug users in primary care and criteria for audit. Royal College of General Practitioners 2005; p 1-6. http://www.smmgp.org.uk/download/guidance/guidance014.pdf. Accessed January 11, 2015
   Google Scholar
• Costumbrado J, Stirland A, Cox G, El-Amin AN, Miranda A, Carter A, Malek M. Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007-2010. Vaccine 2012; 30(48):6878-82; PMID:22989688; http://dx.doi.org/10.1016/j.vaccine.2012.09.006
   PubMed Web of Science ®Google Scholar
• Keystone JS, Hershey JH. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule. Int J Infect Dis 2008;12(1):3-11; PMID:17643334; http://dx.doi.org/10.1016/j.ijid.2007.04.012
   PubMed Web of Science ®Google Scholar
• Jacobs RJ, Rosenthal P, Meyerhoff AS. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates. Vaccine 2004; 22(9–10):1241-8; PMID:15003653; http://dx.doi.org/10.1016/j.vaccine.2003.09.018
   PubMed Web of Science ®Google Scholar
• World Health Organization. Tetanus. Fact Sheets 2012. http://www.wpro.who.int/mediacentre/factsheets/fs_20120307_tetanus/en/. Accessed January 11, 2015
   Google Scholar
• World Health Organization. Diphtheria. Immunization, surveillance, assessment and monitoring 2012. http://www.who.int/immunization/monitoring_surveillance/burden/diphtheria/en/. Accessed January 11, 2015
   Google Scholar
• World Health Organization. Pertussis. Immunization, Vaccines and Biologicals. http://www.who.int/immunization/diseases/pertussis/en/. Accessed January 11, 2015
   Google Scholar
• Bartlett L, Kanellos-Sutton M, van Wylick R. Immunization rates in a Canadian juvenile corrections facility. J Adolesc Health 2008; 43(6):609-11; PMID:19027650; http://dx.doi.org/10.1016/j.jadohealth.2008.04.008
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. second printing. Atkinson W, Wolfe S, Hamborsky J, eds. 12th ed., Washington DC: Public Health Foundation; 2012
   Google Scholar
• World Health Organization. Pneumococcal disease. International travel and health 2012. http://www.who.int/ith/diseases/pneumococcal/en/. Accessed January 11, 2015
   Google Scholar
• Mehiri-Zghal E, Decousser J-W, Mahjoubi W, Essalah L, El Marzouk N, Ghariani A, Allouch P, Slim-Saidi NL. Molecular epidemiology of a Streptococcus pneumoniae serotype 1 outbreak in a Tunisian jail. Diagn Microbiol Infect Dis 2010; 66(2):225-7; PMID:19800751; http://dx.doi.org/10.1016/j.diagmicrobio.2009.05.008
   PubMed Web of Science ®Google Scholar
• Hoge CW, Reichler MR, Dominguez EA, Bremer JC, Mastro TD, Hendricks KA, Musher DM, Elliott JA, Facklam RR, Breiman RF. An epidemic of Pneumococical disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994; 331(10):643-8; PMID:8052273; http://dx.doi.org/10.1056/NEJM199409083311004
   PubMed Web of Science ®Google Scholar
• Herbert K, Plugge E, Foster C, Doll H. Prevalence of risk factors for non-communicable diseases in prison populations worldwide: a systematic review. Lancet 2012; 379(9830):1975-82; PMID:22521520; http://dx.doi.org/10.1016/S0140-6736(12)60319-5
   PubMed Web of Science ®Google Scholar
• Bayas J, Vilella A. Vacunas para la población penitenciaria. Rev Española Sanid Penit 2002 [cited 2014 Dec 23]; (4):39-42
   Google Scholar
• Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, White CG, Hadler S, Pilishvili T, Centers for Disease Control and Prevention. Use of 13-Valent pneumococcal conjugate vaccine and 23-Valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2014; 63(37): 822-5; PMID:25233284
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61(40):816-9; PMID:23051612
   PubMedGoogle Scholar
• Public Health England: Health and Justice Team Respiratory Diseases Department, Centre for Disease Surveillance and Control. Guidance on responding to cases or outbreaks of seasonal flu 2014/15 in prisons and other places of detention within the criminal justice system in England. London (UK). Operational guidance 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/371897/Guidance_on_seasonal_flu_2014_to_15_in_prisons.pdf. Accessed December 14, 2015
   Google Scholar
• Gómez-Pintado P, Moreno R, Pérez-Valenzuela A, García-Falcés JI, García M, Martínez MA, Acín E, Fernández de la Hoz K. Descripción de los tres primeros brotes de gripe A (H1N1) 2009 notificados en prisiones de España. Rev Esp Sanid Penit 2010; 12(1):29-36; PMID:23128486
   PubMedGoogle Scholar
• Turner KB, Levy MH. Prison outbreak: pandemic (H1N1) 2009 in an Australian prison. Public Health 2010; 124(2):119-21; PMID:20149400; http://dx.doi.org/10.1016/j.puhe.2009.12.005
   PubMed Web of Science ®Google Scholar
• Maruschak LM, Sabol WJ, Potter RH, Reid LC, Cramer EW. Pandemic influenza and jail facilities and populations. Am J Public Health 2009; 99(SUPPL. 2):S339-44; PMID:19797746; http://dx.doi.org/10.2105/AJPH.2009.175174
   PubMed Web of Science ®Google Scholar
• Health J, Hospital W. Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/2002(H3N2)-like virus. Epidemiol Infect 2005; 133(1):107-12; PMID:15724717; http://dx.doi.org/10.1017/S0950268804003243
   PubMed Web of Science ®Google Scholar
• Stanley L. Influenza at San Quentin Prison, California. Public Health Reports (1896-1970) 1919; 34(19):996-1008. http://www.jstor.org/stable/4575142. Accessed January 8, 2015; http://dx.doi.org/10.2307/4575142
   Google Scholar
• James T, Finnie R, Hall IM, Leach S. Behaviour and control of influenza in institutions and small societies. J R Soc Med 2012; 105(2):66-73; PMID:22357982; http://dx.doi.org/10.1258/jrsm.2012.110249
   PubMed Web of Science ®Google Scholar
• Awofeso N, Fennell M, Waliuzzaman Z, O'Connor C, Pittam D, Boonwaat L, de Kantzow S, Rawlinson WD. Influenza outbreak in a correctional facility. Aust N Z J Public Health 2001; 25(5):443-6; PMID:11688625; http://dx.doi.org/10.1111/j.1467-842X.2001.tb00290.x
   PubMed Web of Science ®Google Scholar
• Public Health England: Health Protection Agency, Prison Infection Prevention Team. Seasonal influenza outbreak at large London prison. Infection Inside 2011; 7(1). http://www.basl.org.uk/uploaded_files/infection%20inside.pdf. Accessed January 5, 2015
   Google Scholar
• Centers for Disease Control and Prevention. Receipt of A(H1N1)pdm09 vaccine by prisons and jails - United States, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep 2012; 60(51–52):1737-40; PMID:22217623
   PubMedGoogle Scholar
• World Health Organization. Global measles and rubella strategic plan: 2012-2020. Geneva 2012. http://www.who.int/immunization/newsroom/Measles_Rubella_StrategicPlan_2012_2020.pdf?ua=1. Accessed February 10, 2015
   Google Scholar
• Gétaz L, Rieder JP, Siegrist CA, Kramer MC, Stoll B, Humair JP, Kossovsky MP, Gaspoz JM, Wolff H. Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prison. Swiss Med Wkly 2011; 141:w13215; PMID:21706449
   PubMedGoogle Scholar
• Nowicki D, Gajewska L, Sosada KA. Measles outbreak registered by the District Sanitary-Epidemiological Station in Częstochowa in 2013. Przegl Epidemiol 2014; 68(3):405-9, 517-20
   PubMedGoogle Scholar
• Walkty A, Van Caeseele P, Hilderman T, Buchan S, Weiss E, Sloane M, Fatoye B. Mumps in prison: description of an outbreak in Manitoba, Canada. Can J Public Health 2011; 102(5):341-4; PMID:22032098
   PubMed Web of Science ®Google Scholar
• van Boven M, Kretzschmar M, Wallinga J, O'Neill PD, Wichmann O, Hahné S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface 2010; 7(52):1537-44; PMID:20392713; http://dx.doi.org/10.1098/rsif.2010.0086
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202(12):1789-99; PMID:21067372; http://dx.doi.org/10.1086/657321
   PubMed Web of Science ®Google Scholar
• Olesen TB, Munk C, Christensen J, Andersen KK, Kjaer SK. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm Infect 2014; 90(6):455-62; PMID:24812407; http://dx.doi.org/10.1136/sextrans-2013-051456
   PubMed Web of Science ®Google Scholar
• Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011; 48(6):540-52; PMID:21575812; http://dx.doi.org/10.1016/j.jadohealth.2011.03.010
   PubMed Web of Science ®Google Scholar
• World Health Organization. Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec 2014; 43(89):465-92; PMID:25346960
   PubMedGoogle Scholar
• de Aguiar SR, Villanova FE, Martins LC, dos Santos MS, Maciel Jde P, Falcão LF, Fuzii HT, Quaresma JA. Human papillomavirus: prevalence and factors associated in women prisoners population from the Eastern Brazilian Amazon. J Med Virol 2014; 86(9):1528-33; PMID:24838771; http://dx.doi.org/10.1002/jmv.23972
   PubMed Web of Science ®Google Scholar
• Chu F-Y, Lin Y-S, Cheng S-H. Human papillomavirus infection in human immunodeficiency virus-positive Taiwanese women incarcerated for illicit drug usage. J Microbiol Immunol Infect 2013; 46(4):282-7; PMID:22841621; http://dx.doi.org/10.1016/j.jmii.2012.06.009
   PubMedGoogle Scholar
• Canche JR, Canul J, Suárez R, de Anda R, González MR. Infección por el Virus del Papiloma Humano en mujeres recluidas en Centros de Readaptación Social en el sureste de México. Rev Esp Sanid Penit 2011; 13:84-90; PMID:22071487; http://dx.doi.org/10.4321/S1575-06202011000300003
   PubMedGoogle Scholar
• de Sanjosé S, Valls I, Paz Cañadas M, Lloveras B, Quintana MJ, Shah KV, Bosch FX. Infección por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas. Med Clin 2000; 115(3):81-4; PMID:10965480; http://dx.doi.org/10.1016/S0025-7753(00)71472-2
   PubMed Web of Science ®Google Scholar
• González C, Canals J, Ortiz M, Muñoz L, Torres M, García-Saiz A, Del Amo J. Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women. Epidemiol Infect 2007; 136:215-21
   PubMed Web of Science ®Google Scholar
• National Health Service England, Public Health England, Health and Justice Team. Public health services for people in prison or other places of detention, including those held in the Children &Young People's Secure Estate. London (UK) 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/383429/29_public_health_services_for_people_in_prison.pdf. Accessed January 10, 2015
   Google Scholar
• Henderson CE, Rich JD, Lally MA. HPV vaccination practices among juvenile justice facilities in the United States. J Adolesc Health 2010; 46(5):495-8; PMID:20413087; http://dx.doi.org/10.1016/j.jadohealth.2009.10.007
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Mueller S, Clark CB, Cropsey KL. Risk factors for cervical cancer in criminal justice settings. J Womens Health (Larchmt) 2011; 20(12):1839-45; PMID:22004180; http://dx.doi.org/10.1089/jwh.2011.2864
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER; Centers for Disease Control and Prevention. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-05):1-30; PMID:25167164
   PubMed Web of Science ®Google Scholar
• World Health Organization. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011; 86(47):521-39; PMID:22128384
   PubMedGoogle Scholar
• Zhang J, Zhou HJ, Xu L, Hu GC, Zhang XH, Xu SP, Liu ZY, Shao ZJ. Molecular characteristics of Neisseria meningitidis isolated during an outbreak in a jail: association with the spread and distribution of ST-4821 complex serogroup C clone in China. Biomed Environ Sci 2013; 26(5):331-7; PMID:23611126
   PubMed Web of Science ®Google Scholar
• Tappero JW, Reporter R, Wenger JD, Ward BA, Reeves MW, Missbach TS, Plikaytis BD, Mascola L, Schuchat A. Meningococcal disease in Los Angeles County, California, and among men in the county jails. N Engl J Med 1996; 335:833-40; PMID:8778600; http://dx.doi.org/10.1056/NEJM199609193351201
   PubMed Web of Science ®Google Scholar
• Sathe PV, Mugumdar RD, Mahurkar SD, Sengupta SR. An outbreak of meningococcal meningitis in a prison (epidemiology and control). Indian J Public Health 1971; 15(3):92-6; PMID:5154305
   PubMedGoogle Scholar
• World Health Organization, Varicella and Herpes Zoster Vaccination Position Paper – June 2014. http://www.who.int/immunization/position_papers/WHO_pp_varicella_herpes_zoster_june2014_summary.pdf Accessed January 8, 2015
   Google Scholar
• Leung J, Lopez AS, Tootell E, Baumrind N, Mohle-Boetani J, Leistikow B, Harriman KH, Preas CP, Cosentino G, Bialek SR, et al. Challenges with controlling varicella in prison settings: experience of California, 2010 to 2011. J Correct Health Care 2014; 20(4):292-301; PMID:25201912; http://dx.doi.org/10.1177/1078345814541535
   PubMedGoogle Scholar
• Gétaz L, Siegrist CA, Stoll B, Humair JP, Scherrer Y, Franziskakis C, Sudre P, Gaspoz JM, Wolff H. Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures. Scand J Infect Dis 2010; 42(11–12):936-40; PMID:20854218; http://dx.doi.org/10.3109/00365548.2010.511259
   PubMed Web of Science ®Google Scholar
• Valdarchi C, Farchi F, Dorrucci M, De Michetti F, Paparella C, Babudieri S, Spano A, Starnini G, Rezza G. Epidemiological investigation of a varicella outbreak in an Italian prison. Scand J Infect Dis 2008; 40(11–12):943-5; PMID:18720259; http://dx.doi.org/10.1080/00365540802308449
   PubMed Web of Science ®Google Scholar
• Levy MH, Quilty S, Young LC, Hunt W, Matthews R, Robertson PW. Pox in the docks: varicella outbreak in an Australian prison system. Public Health 2003; 117(6):446-51; PMID:14522161; http://dx.doi.org/10.1016/S0033-3506(03)00138-0
   PubMed Web of Science ®Google Scholar
• Haas EJ, Dukhan L, Goldstein L, Lyandres M, Gdalevich M. Use of vaccination in a large outbreak of primary varicella in a detention setting for African immigrants. Int Health 2014; 6(3):203-7; PMID:24682723; http://dx.doi.org/10.1093/inthealth/ihu017
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report, 2014. http://www.who.int/tb/publications/global_report/es/ Accessed January 05, 2015
   Google Scholar
• World Health Organization. Tuberculosis in prisons Page [Internet]. http://www.who.int/tb/challenges/prisons/en/. Accessed January 10, 2015
   Google Scholar
• World Health Organizaction. Literature Review on Tuberculosis in Prisons, 2008. http://www.who.int/tb/challenges/prisons/tb_in_prisons_lit_review_10feb08.pdf?. Accessed January 12, 2015
   Google Scholar
• World Health Organizaction. Implementing the WHO stop TB strategy: A handbook for national tuberculosis control programmes. Geneve 2008. http://whqlibdoc.who.int/publications/2008/9789241546676_eng.pdf. Accessed January 12, 2015
   Google Scholar
• Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep 2006; 55(RR-9):1-44; PMID:16826161
   PubMedGoogle Scholar
• Schmitt J, Warner K, Gupta S. The high budgetary cost of incarceration. Washington; DC: Center for Economic and Policy Research; 2010. http://www.cepr.net/documents/publications/incarceration-2010-06.pdf. Accessed April 10, 2015
   Google Scholar
• World Health Organization, United Nation Office for Drug and Cirme. Good governance for prison health in the 21st century. Denmark 2013. http://www.euro.who.int/__data/assets/pdf_file/0017/231506/Good-governance-for-prison-health-in-the-21st-century.pdf?ua=1. Accessed January 20, 2015
   Google Scholar
• Saiz de la Hoya P. Integración de la Sanidad Penitenciaria. Perspectivas de futuro. Rev Esp Sanid Penit 2012; 2:83-6
   Google Scholar
• Departament of Health England. Prison Health Performance and Quality Indicators 2012 [Internet]. https://www.gov.uk/government/publications/prison-health-performance-and-quality-indicator-report-and-guidance. Accessed January 16, 2015
   Google Scholar
• Christensen PB1, Fisker N, Krarup HB, Liebert E, Jaroslavtsev N, Christensen K, Georgsen J. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine 2004; 22(29–30):3897-901; PMID:15364437; http://dx.doi.org/10.1016/j.vaccine.2004.04.011
   PubMed Web of Science ®Google Scholar
• Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health 2001; 78(2):214-35; PMID:11419576; http://dx.doi.org/10.1093/jurban/78.2.214
   PubMed Web of Science ®Google Scholar
• Glaser J, Greifinger R. Correctional health care: a public health opportunity. Ann Intern Med 1993; 1995(5):6-8; PMID:8416310
   PubMed Web of Science ®Google Scholar
• Maher D, Grzemska M, Coninx R, Reyes H. Guidelines for the control of tuberculosis in prisons. WHO/TB/98.250. 1998. http://whqlibdoc.who.int/hq/1998/WHO_TB_98.250.pdf Accesed 8 January, 2015
   Google Scholar